The U.S. Food and Drug Administration (FDA) has approved Lasix ONYU (furosemide injection), a new drug-device combination ...
Rather than using their federal 340B drug discount savings to lower costs for patients, many hospitals reinvest their profits into acquiring independent clinics.
Eli Lilly and Co said on Wednesday the U.S. government has purchased 650,000 additional doses of its COVID-19 antibody drug for $812.5 million.
Eli Lilly and Co on Wednesday said a single infusion of its experimental antibody treatment reduced the need for hospitalization and emergency room visits for clinical trial patients with moderate ...
In the Lancet Child & Adolescent Health Commission on the future of neonatology, Daniele De Luca and colleagues call for ...
SurvivorNet on MSN
FDA Approves New Subcutaneous (Under-the-Skin) Option for Keytruda: What It Means for Cancer Patients
The U.S. Food and Drug Administration (FDA) has approved the subcutaneous form of Keytruda for a new 'Under-the-Skin' Option for patients. The subcutaneous form of Keytruda showed to deliver the same ...
Everyday Health on MSN
Blockbuster Cancer Drug Keytruda Now Available as a Time-Saving Shot
So-called checkpoint proteins on immune cells serve as gatekeepers that are supposed to keep foreign invaders from entering healthy cells. Certain cancers use these checkpoints to avoid detection.
The Dominican Republic has indicated that a boat targeted by a U.S. airstrike had been ferrying "approximately 1,000 kilograms of suspected cocaine." That figure converts to more than 2,200 pounds, ...
Lower the costs of development for American scientists, too. Scott Gottlieb is a senior fellow at the American Enterprise Institute and a partner at New Enterprise Associates, a venture capital firm.
The U.S. Department of Health and Human Services and the Food and Drug Administration announced major reform on Tuesday that requires pharmaceutical companies to include full safety warnings in direct ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results